Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Kedudukan dalam Saham #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Harga Saham
$70.50
Disegerakkan terakhir: 2025-11-14
Modal Pasaran
$7.33B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
116.32%
Negara
US
Perdagangan Metsera, Inc. (MTSR)

Kategori

Sejarah harga saham bagi Metsera, Inc. (MTSR)
Harga penutupan tertinggi: $72.34 pada 2025-11-01

Harga penutupan terendah: $26.50 pada 2025-01-01
Sejarah harga saham Metsera, Inc. dari 2025 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -29.98%
2025 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH